Pmv Pharmaceuticalsinc Stock Working Capital
| PMVP Stock | USD 2.10 0.05 2.33% |
Pmv PharmaceuticalsInc fundamentals help investors to digest information that contributes to Pmv PharmaceuticalsI's financial success or failures. It also enables traders to predict the movement of Pmv Stock. The fundamental analysis module provides a way to measure Pmv PharmaceuticalsI's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pmv PharmaceuticalsI stock.
| Last Reported | Projected for Next Year | ||
| Net Working Capital | 193.4 M | 226.3 M | |
| Change In Working Capital | 5.4 M | 5.7 M | |
| Working Capital | 0.00 | 0.00 |
Pmv | Working Capital |
Pmv PharmaceuticalsInc Company Working Capital Analysis
Pmv PharmaceuticalsI's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Pmv PharmaceuticalsI Working Capital | 193.38 M |
Most of Pmv PharmaceuticalsI's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pmv PharmaceuticalsInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Pmv Working Capital Driver Correlations
Understanding the fundamental principles of building solid financial models for Pmv PharmaceuticalsI is extremely important. It helps to project a fair market value of Pmv Stock properly, considering its historical fundamentals such as Working Capital. Since Pmv PharmaceuticalsI's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pmv PharmaceuticalsI's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pmv PharmaceuticalsI's interrelated accounts and indicators.
Click cells to compare fundamentals
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
Pmv Net Invested Capital
Net Invested Capital |
|
Based on the company's disclosures, Pmv PharmaceuticalsInc has a Working Capital of 193.38 M. This is 54.57% lower than that of the Biotechnology sector and 64.1% lower than that of the Health Care industry. The working capital for all United States stocks is 86.92% higher than that of the company.
Pmv Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pmv PharmaceuticalsI's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pmv PharmaceuticalsI could also be used in its relative valuation, which is a method of valuing Pmv PharmaceuticalsI by comparing valuation metrics of similar companies.Pmv PharmaceuticalsI is currently under evaluation in working capital category among related companies.
Pmv PharmaceuticalsI Current Valuation Drivers
We derive many important indicators used in calculating different scores of Pmv PharmaceuticalsI from analyzing Pmv PharmaceuticalsI's financial statements. These drivers represent accounts that assess Pmv PharmaceuticalsI's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Pmv PharmaceuticalsI's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.6B | 2.8B | 1.0B | 396.7M | 148.8M | 141.4M | |
| Enterprise Value | 1.7B | 2.4B | 881.4M | 302.4M | 123.6M | 117.4M |
Pmv PharmaceuticalsI ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Pmv PharmaceuticalsI's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Pmv PharmaceuticalsI's managers, analysts, and investors.Environmental | Governance | Social |
Pmv Fundamentals
| Return On Equity | -0.29 | ||||
| Return On Asset | -0.19 | ||||
| Current Valuation | (76.89 M) | ||||
| Shares Outstanding | 51.44 M | ||||
| Shares Owned By Insiders | 2.60 % | ||||
| Shares Owned By Institutions | 92.21 % | ||||
| Number Of Shares Shorted | 2.82 M | ||||
| Price To Book | 0.41 X | ||||
| EBITDA | (78.88 M) | ||||
| Net Income | (68.96 M) | ||||
| Cash And Equivalents | 277.43 M | ||||
| Cash Per Share | 6.08 X | ||||
| Total Debt | 13.29 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 24.76 X | ||||
| Book Value Per Share | 4.13 X | ||||
| Cash Flow From Operations | (55.66 M) | ||||
| Short Ratio | 6.22 X | ||||
| Earnings Per Share | (1.32) X | ||||
| Price To Earnings To Growth | (0.31) X | ||||
| Target Price | 8.2 | ||||
| Number Of Employees | 63 | ||||
| Beta | 1.55 | ||||
| Market Capitalization | 108.03 M | ||||
| Total Asset | 252.15 M | ||||
| Retained Earnings | (310 M) | ||||
| Working Capital | 193.38 M | ||||
| Net Asset | 252.15 M |
About Pmv PharmaceuticalsI Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pmv PharmaceuticalsInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pmv PharmaceuticalsI using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pmv PharmaceuticalsInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Pmv PharmaceuticalsI Piotroski F Score and Pmv PharmaceuticalsI Altman Z Score analysis. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Pmv Stock analysis
When running Pmv PharmaceuticalsI's price analysis, check to measure Pmv PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv PharmaceuticalsI is operating at the current time. Most of Pmv PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Pmv PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Pmv PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Pmv PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pmv PharmaceuticalsI. If investors know Pmv will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pmv PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.32) | Return On Assets (0.19) | Return On Equity (0.29) |
The market value of Pmv PharmaceuticalsInc is measured differently than its book value, which is the value of Pmv that is recorded on the company's balance sheet. Investors also form their own opinion of Pmv PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Pmv PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pmv PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Pmv PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pmv PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pmv PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pmv PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.